Section Arrow
Quote
WHWK.NASDAQ
- Whitehawk Therapeutics Inc
Quotes are at least 15-min delayed:2025/03/20 05:37 EDT
Last
 2.02
-0.03 (-1.46%)
Day High 
2.2 
Prev. Close
2.05 
1-M High
-- 
Volume 
76.50K 
Bid
1
Ask
2.19
Day Low
1.77 
Open
1.77 
1-M Low
-- 
Market Cap 
94.89M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High 3.812 
52-W Low 1.21 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.28/-0.72
Enterprise Value
95.72M
Balance Sheet
Book Value Per Share
1.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
24.35M
Operating Revenue Per Share
0.47
Created with Highstock 5.0.121-min Chart10:0013:0016:001.71.81.922.12.22.3etnet.com.hk@copyright
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BDTXBlack Diamond Therapeutics1.72+0.04+2.38%-- 
VRPXVirpax Pharmaceuticals0.109-0.021-16.15%-- 
ADTXAditxt Inc10.03+2.53+33.73%-- 
BDRXBiodexa Pharmaceuticals plc2.34+0.325+16.13%-- 
OCEAOcean Biomedical0.0605+0.0017+2.89%-- 
Quotes are at least 15-min delayed：2025/03/20 05:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.